The urokinase system in patients with intermittent and persistent allergic rhinitis

Blood Coagulation and Fibrinolysis

Volumn 19, Issue 7, 2008, Pages 685-688

  Kasperska Zajac, Alicja ^a,b   Brzoza, Zenon ^a   Rogala, Barbara ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Clinical Department of Internal Diseases Allergology and Clinical Immunology   (Poland)

Author keywords

Allergic rhinitis; Plasminogen activator inhibitor type 1; Urokinase type plasminogen activator; Urokinase type plasminogen activator receptor

Indexed keywords

ALLERGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE; UROKINASE RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DERMATOPHAGOIDES; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GRASS POLLEN; HAY FEVER; HUMAN; MALE; PERENNIAL RHINITIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; FIBRINOLYSIS; HUMANS; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; YOUNG ADULT;

EID: 55049128990     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32830b287d     Document Type: Article

References (21)

1. Blasi F. uPA uPAR, PAI-1: key intersection of proteolytic adhesive and chemotactic highways? Immunol Today 1997; 18:415-417.
2. Horrevoets AJG. Plasminogen activator inhibitor 1 (PAI-1): in vitro activities and clinical relevance. Br J Haematol 2004; 125:12-23.
3. Ferrero E, Vettoretto K, Bondanza A, Villa A, Resnati M, Poggi A, Zocchi MR. uPA/uPAR system is active in immature dendritic cells derived from CD14+ CD34+ precursors and is down-regulated upon maturation. J Immunol 2000; 164:712-718.
4. Mabilat-Pragnon C, Janin A, Michel L, Thomaïdis A, Legrand Y, Soria C, Lu H. Urokinase localization and activity in isolated eosinophils. Thromb Res 1997; 88:373-379.
5. Guilbert M, Ferland C, Bossé, Flamand N, Lavigne S, Laviolette M. 5-Oxo-6,8,11,14-eicosatetraenoic acid induces important eosinophil transmigration through basement membrane components: comparison of normal and asthmatic eosinophils. Am J Respir Cell Mol Biol 1999; 21:97-104.
6. Sillaber C, Baghestanian M, Hofbauer R, Virgolini I, Bankl HC, Füreder W, et al. Molecular and functional characterization of the urokinase receptor on human mast cells. J Biol Chem 1997; 272:7824-7832.
7. Gyetko MR, Sud S, Chensue SW. Urokinase-deficient mice fail to generate a type 2 immune response following Schistosomal antigen challenge. Infect Immun 2004; 72:461-467.
8. Gyetko MR, Sud S, Sonstein J, Polak T, Sud A, Curtis JL. Antigen-derived lymphocyte recruitment to the lung is diminished in the absence of urokinase-type plasminogen activator (uPA) receptor, but is independent of uPA. J Immunol 2001; 167:5539-5542.
9. Banach-Wawrzeńczyk E, Dziedziczko A, Rość D. Fibrinolysis system in patients with bronchial asthma. Med Sci Monit 2000; 6:103-107.
10. Lotti T, Battini ML, Brunetti L, Fabbri P, Panconesi E. Plasminogen activators and antiplasmin activity in atopic dermatitis. Int J Dermatol 1989; 26:457-459.
11. Leonardi A, Brun P, Sartori MT, Cortivo R, Dedominicis C, Saggiorato G, et al. Urokinase plasminogen activator, uPA receptor, and its inhibitor in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci 2005; 46:1364-1370.
12. Sejima T, Madoiwa S, Mimuro J, Sugo T, Ishida T, Ichimura K, Sakata Y. Expression profiles of fibrinolytic components in nasal mucosa. Histochem Cell Biol 2004; 122:61-73.
13. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108 (Suppl 5):S147-S334.
14. Borish L. Allergic rhinitis: systemic inflammation and implications for management. J Allergy Clin Immunol 2003; 112:1021-1031.
15. Jousilahti P, Salomaa V, Hakala K, Rasi V, Vahtera E, Palosuo T. The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol 2002; 89:381-385.
16. Emeis JJ, Kluft C. PAF-acether-induced release of tissue-type plasminogen activator from vessel walls. Blood 1985; 66:86-91.
17. Cicala C, Cirino G. Linkage between inflammation and coagulation: an update on the molecular basis of the crosstalk. Life Sci 1998; 62:1817-1824.
18. Kasperska-Zajac A, Rogala B. Platelet activation during allergic inflammation. Inflammation 2006; 30:161-166.
19. Matthay MA, Clements JA. Coagulation-dependent mechanisms and asthma. J Clin Invest 2004; 114:20-23.
20. Kasperska-Zajac A, Rogala B. Circulating levels of urokinase-type plasminogen activator (uPA) and its soluble receptor (suPAR) in patients with atopic eczema/dermatitis syndrome. Inflammation 2005; 29:90-93.
21. Tutluoglu B, Gurel CB, Ozdas SB, Musellim B, Erturan S, Anakkaya AN, et al. Platelet function and fibrinolytic activity in patients with bronchial asthma. Clin Appl Thromb Hemost 2005; 11:77-81.